| abstract |
The invention is directed to a method of treating cancer in an individual in need thereof comprising administering an effective amount of a slow-releasing H 2 S compound. In another aspect, the invention is directed to a method ( e.g ., in vitro ; in vivo ) of killing and/or inhibiting ( e.g ., selectively killing and/or inhibiting) the growth (proliferation) of a (one or more) cancer cell(s) comprising contacting cells which comprise cancer cells ( e.g ., a heterogeneous population of cells) with an effective amount of a slow-releasing H 2 S compound. A combination is thereby produced and the combination is maintained under conditions in which H 2 S is slowly released in the presence of the cells, thereby killing and/or inhibiting the growth of the cancer cells. |